Sorsby fundus dystrophy. A family with the Ser181Cys mutation of the tissue inhibitor of metalloproteinases 3

R. D. Carrero-Valenzuela, M. L. Klein, R. G. Weleber, W. H. Murphey and M. Litt
Department of Molecular and Medical Genetics, Oregon Health Sciences University, Portland, USA.

Sorbsy fundus dystrophy (SFD) is an autosomal dominant disorder that is characterized by bilateral loss of central vision secondary to choroidal neovascularization and/or pigment epithelial atrophy in the macula, with onset of visual symptoms usually in the fourth or fifth decade. Drusenlike changes may occur, with impaired dark adaptation and abnormal electroretinographic results.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Matrix bound SFD mutant TIMP-3 is more stable than wild type TIMP-3
Majid et al.
Br. J. Ophthalmol. 2007;91:1073-1076.
ABSTRACT | FULL TEXT  

Sorsby fundus dystrophy without a mutation in the TIMP-3 gene
Assink et al.
Br. J. Ophthalmol. 2000;84:682-686.
ABSTRACT | FULL TEXT  

Autosomal Dominant Hemorrhagic Macular Dystrophy Not Associated With the TIMP3 Gene
Ayyagari et al.
Arch Ophthalmol 2000;118:85-92.
ABSTRACT | FULL TEXT  

Accumulation of tissue inhibitor of metalloproteinases-3 in human eyes with Sorsby's fundus dystrophy or retinitis pigmentosa
Fariss et al.
Br. J. Ophthalmol. 1998;82:1329-1334.
ABSTRACT | FULL TEXT